Navigation Links
American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage
Date:12/4/2008

d that: there are 50 percent fewer general surgeons today than there were 20 years ago (79 percent concerned); there are not enough qualified surgeons to staff emergency trauma centers across the country (89 percent); the number of medical students who become general surgeons has decreased 30 percent over the last 10 years (81 percent); and three-quarters of U.S. hospitals say they don't have enough specialty surgeons to treat their patients (86 percent).

To ensure the United States has a well-trained and available surgical workforce to meet patient needs, the College encourages lawmakers to create policies that:

  • Help eliminate disparities in surgical care by expanding the National Health Service Corps to include surgeons. The College believes that doing so will help increase public service and also assist surgeons with medical school debt.
  • Support and help fund a national health workforce database to identify areas with little or no access to surgical care.
  • Explore alternative methods for paying for health care to ensure the presence of an adequate and robust surgical workforce over time by working with the ACS to develop a demonstration program.
  • Reduce medical errors, improve safety, provide patients with higher quality care, and potentially reduce the incidence of medical liability cases by partnering with the College and the surgical community to test surgical and patient safety initiatives.

"It is our job to ensure that all Americans have access to innovative, high-quality, and affordable surgical care," said Thomas R. Russell, MD, FACS, ACS Executive Director. "Creating an environment in which all patients -- rural or urban, wealthy or poor -- have access to the surgical care they need must be an essential element of health care reform. We look forward to working with policymakers, patient advocates, and
'/>"/>

SOURCE American College of Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Almost Two-Thirds of Americans Meet Exercise Guidelines
2. American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center
3. American Academy of Dermatology Issues Position Statement on Vitamin D
4. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
5. Universal American Announces New Patient Care Program
6. Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology
7. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
8. American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours
9. Biocept Awarded Accreditation by the College of American Pathologists
10. New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome
11. Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10VAs Health System Top Employer for AARP 58061 1VAs Health System Top Employer for AARP 58061 2Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 1Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 2Journalists invited to Darwin Chicago 2009 conference Oct 29 31 10039 1